SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-100357
Filing Date
2022-04-08
Accepted
2022-04-08 16:20:01
Documents
8
Period of Report
2022-05-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A d303460ddef14a.htm DEF 14A 340992
2 GRAPHIC g303460g86y42.jpg GRAPHIC 1484
3 GRAPHIC g303460sp01.jpg GRAPHIC 1838
4 GRAPHIC g303460sp01a.jpg GRAPHIC 1070
5 GRAPHIC g303460sp01b.jpg GRAPHIC 968
6 GRAPHIC g303460sp02.jpg GRAPHIC 972
7 GRAPHIC g303460spiii1.jpg GRAPHIC 1177
8 GRAPHIC g303460spvii01.jpg GRAPHIC 1042
  Complete submission text file 0001193125-22-100357.txt   354833
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 425-276-2300
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40708 | Film No.: 22817249
SIC: 2834 Pharmaceutical Preparations